$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000143774920024024 Filed on November 16, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$1.060M	$943.3K	$452.7K
YoY Change	100.0%	108.37%	-38.8%
Cost Of Revenue	$310.0K	$211.6K	$508.7K
YoY Change	-53.73%	-58.4%	-45.91%
Gross Profit	$750.0K	$731.7K	-$55.94K
YoY Change	-676.92%	-1408.06%	-72.11%
Gross Profit Margin	70.75%	77.57%	-12.36%
Selling, General & Admin	$1.770M	$1.490M	$915.1K
YoY Change	4.73%	62.86%	-12.79%
% of Gross Profit	236.0%	203.66%
Research & Development	$410.0K	$331.2K	$300.1K
YoY Change	13.89%	10.36%	-23.34%
% of Gross Profit	54.67%	45.27%
Depreciation & Amortization	$130.0K	$30.00K	$300.0K
YoY Change	116.67%	-90.0%	-56.52%
% of Gross Profit	17.33%	4.1%
Operating Expenses	$2.180M	$1.821M	$1.215M
YoY Change	6.86%	49.89%	-15.66%
Operating Profit	-$1.430M	-$1.090M	-$558.4K
YoY Change	-34.1%	95.14%	-65.98%
Interest Expense	-$20.00K	$2.205M	$558.4K
YoY Change	-95.0%	294.83%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$2.204M	-$1.271M
YoY Change		73.37%
Pretax Income	-$1.440M	-$3.290M	-$1.830M
YoY Change	-84.89%	79.78%	11.59%
Income Tax
% Of Pretax Income
Net Earnings	-$1.440M	-$3.294M	-$1.830M
YoY Change	-84.89%	80.02%	11.47%
Net Earnings / Revenue	-135.85%	-349.14%	-404.13%
Basic Earnings Per Share
Diluted Earnings Per Share	-$184.4K	-$510.9K	-$1.017M
COMMON SHARES
Basic Shares Outstanding	62.41M		14.40M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.51M	$18.91M	$590.0K
YoY Change	2867.8%	3105.08%	-43.81%
Cash & Equivalents	$16.99M	$18.40M	$78.24K
Short-Term Investments	$510.0K	$520.0K	$510.0K
Other Short-Term Assets	$60.45K	$63.26K	$50.70K
YoY Change	-45.51%	24.77%	-36.94%
Inventory	$330.9K	$399.4K	$971.2K
Prepaid Expenses
Receivables	$548.0K	$492.4K	$773.3K
Other Receivables	$350.0K	$360.0K	$50.00K
Total Short-Term Assets	$18.94M	$20.37M	$3.694M
YoY Change	1286.37%	451.25%	-37.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$81.79K	$78.94K	$117.6K
YoY Change	-14.36%	-32.9%	-30.81%
Goodwill	$1.263M	$1.155M
YoY Change
Intangibles	$1.514M	$1.617M	$187.7K
YoY Change	880.75%	761.57%	-2.75%
Long-Term Investments
YoY Change
Other Assets	$170.0K	$160.0K	$260.0K
YoY Change	-29.17%	-38.46%	-23.53%
Total Long-Term Assets	$3.579M	$3.635M	$7.087M
YoY Change	216.58%	-48.71%	-0.07%
TOTAL ASSETS
Total Short-Term Assets	$18.94M	$20.37M	$3.694M
Total Long-Term Assets	$3.579M	$3.635M	$7.087M
Total Assets	$22.52M	$24.00M	$10.78M
YoY Change	802.01%	122.6%	-17.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$244.2K	$314.5K	$496.7K
YoY Change	-71.09%	-36.67%	34.31%
Accrued Expenses	$508.5K	$399.8K	$478.5K
YoY Change	-11.24%	-16.46%	-18.28%
Deferred Revenue	$657.3K	$773.0K	$222.7K
YoY Change	83.0%	247.08%	-12.91%
Short-Term Debt	$232.0K	$235.0K	$1.860M
YoY Change		-87.37%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.876M	$1.952M	$3.236M
YoY Change	-57.27%	-39.67%	167.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$310.0K	$370.0K	$430.0K
YoY Change	-20.51%	-13.95%
Total Long-Term Liabilities	$309.2K	$365.9K	$426.9K
YoY Change	-20.83%	-14.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.876M	$1.952M	$3.236M
Total Long-Term Liabilities	$309.2K	$365.9K	$426.9K
Total Liabilities	$2.185M	$2.318M	$3.663M
YoY Change	-54.3%	-36.71%	202.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.51M	-$98.07M	-$80.19M
YoY Change	10.91%	22.3%	8.73%
Common Stock	$782.00	$6.237K	$1.440K
YoY Change	329.67%	333.13%	3.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.34M	$21.68M	$7.119M
YoY Change
Total Liabilities & Shareholders Equity	$22.52M	$24.00M	$10.78M
YoY Change	802.01%	122.6%	-17.07%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$1.440M	-$3.294M	-$1.830M
YoY Change	-84.89%	80.02%	11.47%
Depreciation, Depletion And Amortization	$130.0K	$30.00K	$300.0K
YoY Change	116.67%	-90.0%	-56.52%
Cash From Operating Activities	-$1.260M	-$1.720M	-$1.620M
YoY Change	-4300.0%	6.17%	58.82%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	-$10.00K	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$10.00K	-$300.0K	-$510.0K
YoY Change		-41.18%
Cash From Investing Activities	-$30.00K	-$290.0K	-$510.0K
YoY Change		-43.14%	5000.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-120.0K	19.53M	1.530M
YoY Change	300.0%	1176.47%	-14.04%
NET CHANGE
Cash From Operating Activities	-1.260M	-1.720M	-1.620M
Cash From Investing Activities	-30.00K	-290.0K	-510.0K
Cash From Financing Activities	-120.0K	19.53M	1.530M
Net Change In Cash	-1.410M	17.52M	-600.0K
YoY Change	320312271728132100.0%	-3020.0%	-180.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.260M	-$1.720M	-$1.620M
Capital Expenditures	-$30.00K	-$10.00K	$0.00
Free Cash Flow	-$1.230M	-$1.710M	-$1.620M
YoY Change	-4200.0%	5.56%	60.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights	843287
	bkyi	Beneficial Conversion Feature BeneficialConversionFeature	641215
	bkyi	Beneficial Conversion Feature BeneficialConversionFeature
CY2020Q2	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	199328
CY2020Q3	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	-2171896
CY2019Q3	bkyi	Adjustments To Additional Paid In Capital Legal And Commitment Fees AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees	-272985
CY2019Q3	bkyi	Adjustments To Additional Paid In Capital Warrant Debt Discount Valuation AdjustmentsToAdditionalPaidInCapitalWarrantDebtDiscountValuation	595662
	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	641215
	bkyi	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature
	bkyi	Amortization Of Software License Rights AmortizationOfSoftwareLicenseRights
	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	184792
	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired
	bkyi	Business Combination Accrued Expenses Acquired BusinessCombinationAccruedExpensesAcquired	20017
	bkyi	Business Combination Accrued Expenses Acquired BusinessCombinationAccruedExpensesAcquired
	bkyi	Business Combination Deferred Revenue Acquired BusinessCombinationDeferredRevenueAcquired	590000
	bkyi	Business Combination Deferred Revenue Acquired BusinessCombinationDeferredRevenueAcquired
	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	36467
	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired
	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	1480000
	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired
	bkyi	Business Combination Issuance Of Notes Payable BusinessCombinationIssuanceOfNotesPayable	356000
	bkyi	Business Combination Issuance Of Notes Payable BusinessCombinationIssuanceOfNotesPayable
	bkyi	Business Combination Prepaid Expenses Acquired BusinessCombinationPrepaidExpensesAcquired	9485
	bkyi	Business Combination Prepaid Expenses Acquired BusinessCombinationPrepaidExpensesAcquired
CY2019Q3	bkyi	Class Of Warrant Or Right Recorded As Debt Discount ClassOfWarrantOrRightRecordedAsDebtDiscount	595662
CY2020Q1	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact	-900000
CY2020Q3	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact
CY2019Q2	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact	-270000
CY2019Q3	bkyi	Commitment Fee Adjustment Equity Impact CommitmentFeeAdjustmentEquityImpact
CY2020Q1	bkyi	Deemed Dividend Related To Down Round Features DeemedDividendRelatedToDownRoundFeatures
CY2020Q3	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	-64742
CY2019Q4	bkyi	Factored Accounts Receivable Factored Amount FactoredAccountsReceivableFactoredAmount	-122064
CY2020Q3	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	128004
CY2019Q4	bkyi	Factored Accounts Receivable Original Invoice Value FactoredAccountsReceivableOriginalInvoiceValue	233005
	bkyi	Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter	150000
CY2020Q3	bkyi	Factoring Fees FactoringFees	15934
CY2019Q3	bkyi	Factoring Fees FactoringFees	32891
	bkyi	Factoring Fees FactoringFees	81164
	bkyi	Factoring Fees FactoringFees	125231
CY2020Q3	bkyi	Government Grant Income GovernmentGrantIncome
CY2019Q3	bkyi	Government Grant Income GovernmentGrantIncome
	bkyi	Government Grant Income GovernmentGrantIncome	340819
	bkyi	Government Grant Income GovernmentGrantIncome
	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	29808
	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	38597
	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-147480
	bkyi	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	14667
	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-5044
	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	-40857
	bkyi	Investment In Held To Maturity Debt Securities Term InvestmentInHeldToMaturityDebtSecuritiesTerm	P1Y
CY2019Q2	bkyi	Investment In Heldtomaturity Debt Securities Interest Rate InvestmentInHeldtomaturityDebtSecuritiesInterestRate	0.05
CY2020Q2	bkyi	Investment In Heldtomaturity Debt Securities Interest Rate InvestmentInHeldtomaturityDebtSecuritiesInterestRate	0.05
CY2020Q2	bkyi	Limit Of Bond LimitOfBond	20000000
	bkyi	Monthly Cash Requirement To Conduct Operations And Pay Dividend Obligations MonthlyCashRequirementToConductOperationsAndPayDividendObligations	680000
	bkyi	Operating Lease Liability Assumed Under Asc842 OperatingLeaseLiabilityAssumedUnderAsc842	141761
	bkyi	Operating Lease Liability Assumed Under Asc842 OperatingLeaseLiabilityAssumedUnderAsc842	707217
	bkyi	Operating Lease Rightofuse Asset Amortization Expense Reversal Of Expense OperatingLeaseRightofuseAssetAmortizationExpenseReversalOfExpense	151325
	bkyi	Operating Lease Rightofuse Asset Amortization Expense Reversal Of Expense OperatingLeaseRightofuseAssetAmortizationExpenseReversalOfExpense	-8946
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Banker Fees PaymentsOfStockIssuanceCostsBankerFees	193500
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Commitment Fees PaymentsOfStockIssuanceCostsCommitmentFees	50000
CY2019Q3	bkyi	Payments Of Stock Issuance Costs Legal Fees PaymentsOfStockIssuanceCostsLegalFees	71330
	bkyi	Percentage Of Remaining Balance Owned Reserved PercentageOfRemainingBalanceOwnedReserved	1
	bkyi	Percentage Of Support And Maintenance Revenue To License Cost PercentageOfSupportAndMaintenanceRevenueToLicenseCost	0.18
	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	687778
	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	765677
	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	277833
	bkyi	Sharebased Commitment Fees SharebasedCommitmentFees	595000
CY2020Q3	bkyi	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	80093
CY2020Q3	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	68758
CY2019Q4	bkyi	Software License Rights Noncurrent SoftwareLicenseRightsNoncurrent	73802
	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	22010
	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	28512
CY2019Q3	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	266667
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	114943
CY2020Q2	bkyi	Stock Issued During Period Shares Issued For Due Diligence Fee StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee	136575
CY2020Q1	bkyi	Stock Issued During Period Shares Warrants Exercises StockIssuedDuringPeriodSharesWarrantsExercises	972000
CY2020Q1	bkyi	Stock Issued During Period Value Conversion Of Warrant StockIssuedDuringPeriodValueConversionOfWarrant	1458000
CY2020Q3	bkyi	Stock Issued During Period Value Conversion Of Warrant StockIssuedDuringPeriodValueConversionOfWarrant	4136795
CY2019Q3	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	400000
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	133333
CY2020Q2	bkyi	Stock Issued During Period Value Issued For Due Diligence Fee StockIssuedDuringPeriodValueIssuedForDueDiligenceFee	100000
CY2020Q3	bkyi	Stock Returned During The Period Shares Commitment Fee StockReturnedDuringThePeriodSharesCommitmentFee	600000
	bkyi	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	1388339
	bkyi	Warrants Issued With Convertible Notes WarrantsIssuedWithConvertibleNotes	595662
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001019034
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62412558
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Registrant Name EntityRegistrantName	BIO KEY INTERNATIONAL INC
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	bkyi
CY2020Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	63262
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	110941
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	314546
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	844557
CY2020Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2226165
CY2019Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	1859785
CY2020Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	506165
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	139785
CY2020Q3	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2019Q4	us-gaap	Accounts Receivable Gross Noncurrent AccountsReceivableGrossNoncurrent	1720000
CY2020Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	492380
CY2019Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	126000
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	492380
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	126000
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	399756
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	572885
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119748463
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	87436402
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	641215
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	512719
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33177
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34306
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17215
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9941
CY2019Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	6957516
CY2020Q3	us-gaap	Assets Assets	24000569
CY2019Q4	us-gaap	Assets Assets	2496698
CY2020Q3	us-gaap	Assets Current AssetsCurrent	20365686
CY2019Q4	us-gaap	Assets Current AssetsCurrent	1366291
CY2020Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	3634883
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1130407
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79013
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	79013
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	509528
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	125549
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	130600
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	12921
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	54230
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	137101
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	709788
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	794189
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1733785
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13785
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Noncurrent AllowanceForDoubtfulAccountsReceivableNoncurrent	1720000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1416040
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	288774
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2166650
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	311718
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	111467
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	102839
CY2020Q3	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P4Y
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	100747
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18395508
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	62376443
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14411432
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62376443
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14411432
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	6237
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	323943
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18395508
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	78240
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18316495
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-245703
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.60
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.65
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.50
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1441
CY2020Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	149860
CY2019Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	231519
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	813505
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	359212
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	773013
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	359212
CY2020Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	40492
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent
CY2020Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	94000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	202000
CY2019Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	89000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	211609
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	508653
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	484326
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1792129
CY2020Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712
	us-gaap	Depreciation Depreciation	59129
	us-gaap	Depreciation Depreciation	59717
CY2020Q1	us-gaap	Dividends Paidinkind DividendsPaidinkind	41688
	us-gaap	Dividends Paidinkind DividendsPaidinkind	112686
	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2020Q3	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2019Q3	us-gaap	Dividends Paidinkind DividendsPaidinkind
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-530011
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	15398
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	181588
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-800698
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-499076
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2020Q3	us-gaap	Goodwill Goodwill	1154526
CY2019Q4	us-gaap	Goodwill Goodwill
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1154526
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod
CY2020Q3	us-gaap	Gross Profit GrossProfit	731716
CY2019Q3	us-gaap	Gross Profit GrossProfit	-55939
	us-gaap	Gross Profit GrossProfit	1288626
	us-gaap	Gross Profit GrossProfit	-59409
CY2019Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4000000
CY2019Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
CY2020Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4000000
CY2020Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	516121
CY2020Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	516121
CY2019Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	512821
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-193146
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-69691
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-135707
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	26112
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-29723
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-27662
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-47679
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-5980
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	86137
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	45000
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1617171
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	154386
CY2020Q3	us-gaap	Interest Expense InterestExpense	2204920
CY2019Q3	us-gaap	Interest Expense InterestExpense	558449
	us-gaap	Interest Expense InterestExpense	4323577
	us-gaap	Interest Expense InterestExpense	673316
	us-gaap	Interest Paid Net InterestPaidNet	99426
	us-gaap	Interest Paid Net InterestPaidNet
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2176820
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2203647
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-543310
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3686069
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1879213
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-3370282
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	258038
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	287761
CY2020Q3	us-gaap	Inventory Net InventoryNet	399396
CY2019Q4	us-gaap	Inventory Net InventoryNet	429119
CY2020Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141358
CY2019Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141358
CY2020Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	25800
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1106
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	19
	us-gaap	Investment Income Interest InvestmentIncomeInterest	26908
	us-gaap	Investment Income Interest InvestmentIncomeInterest	143
CY2020Q3	us-gaap	Lease Cost LeaseCost	67773
	us-gaap	Lease Cost LeaseCost	175219
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	597609
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	256977
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	89226
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	187594
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	63812
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	42302
CY2020Q3	us-gaap	Liabilities Liabilities	2318114
CY2019Q4	us-gaap	Liabilities Liabilities	4781871
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24000569
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2496698
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1952168
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4391405
CY2020Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	365946
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	390466
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24206211
CY2019Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	188737
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	1821454
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	1215198
	us-gaap	Operating Expenses OperatingExpenses	5070243
	us-gaap	Operating Expenses OperatingExpenses	4326236
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2203814
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-558430
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4454926
	us-gaap	Operating Income Loss OperatingIncomeLoss	-673173
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	67773
	us-gaap	Operating Lease Cost OperatingLeaseCost	175219
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	555307
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	229853
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170560
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-1572709
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-3293552
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-1803508
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-1425743
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1829567
	us-gaap	Net Income Loss NetIncomeLoss	-8236543
	us-gaap	Net Income Loss NetIncomeLoss	-5058818
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3293552
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1829567
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8349229
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5058818
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1089738
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1271137
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3781617
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4385645
CY2020Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	295000
CY2019Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2255454
CY2020Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	325454
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	390466
	us-gaap	Operating Lease Payments OperatingLeasePayments	171374
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	556915
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	566479
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y178D
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	63262
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	110941
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2693022
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	333180
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2000000
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	516121
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	512821
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1736
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	295000
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	130000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	188737
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	331213
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	300132
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	986675
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	975466
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-98072245
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6094
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28753
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	204019
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	108397
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3958000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3217000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22174425
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2020Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	22700000
CY2020Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	22700000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	512821
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1458000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5594795
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	78941
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	95509
CY2020Q3	us-gaap	Receivable With Imputed Interest Effective Yield Interest Rate ReceivableWithImputedInterestEffectiveYieldInterestRate	0.05
CY2020Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	4200000
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	4509250
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	707000
CY2020Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	130000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89723016
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	943325
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	452714
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1772952
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1732720
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	556915
	us-gaap	Stock Issued1 StockIssued1	3789000
	us-gaap	Stock Issued1 StockIssued1
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	306000
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1500000
CY2020Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2289000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1032500
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1490241
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	915066
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4083568
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3350770
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	197500
CY2020Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.65
CY2020Q1	us-gaap	Share Price SharePrice	0.76
CY2020Q2	us-gaap	Share Price SharePrice	0.65
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.16
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.7322
CY2020Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	235000
CY2019Q4	us-gaap	Short Term Borrowings ShortTermBorrowings
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	145333
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22174425
CY2019Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	450000
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	415000
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15007
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7003
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16506
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5505
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6501
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	21682455
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-2285173
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-1411021
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	782453
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10466222
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	9188748
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	8074059
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	7119270
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	51486756
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14387467
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29305427
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14163120

Files In Submission

Name	View Source	Status
R25.htm	Edgar Link	pending
0001437749-20-024024-index-headers.html	Edgar Link	pending
0001437749-20-024024-index.html	Edgar Link	pending
0001437749-20-024024.txt	Edgar Link	pending
0001437749-20-024024-xbrl.zip	Edgar Link	pending
bkyi-20200930.xml	Edgar Link	completed
bkyi-20200930.xsd	Edgar Link	pending
bkyi-20200930_cal.xml	Edgar Link	unprocessable
bkyi-20200930_def.xml	Edgar Link	unprocessable
bkyi-20200930_lab.xml	Edgar Link	unprocessable
bkyi-20200930_pre.xml	Edgar Link	unprocessable
bkyi20200930_10q.htm	Edgar Link	pending
ex_213185.htm	Edgar Link	pending
ex_213186.htm	Edgar Link	pending
ex_213187.htm	Edgar Link	pending
ex_213188.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2020 Q4 Form 10-Q Financial Statement

#000143774920024024 Filed on November 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2020 Q4 Form 10-Q Financial Statement

#000143774920024024 Filed on November 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi